PAREXEL Introduces The PAREXEL MyTrials™ Platform, A Fully-integrated eClinical Platform For More Efficient Clinical Trials

PAREXEL International Corporation, a leading global biopharmaceutical services provider, today announced the launch of the PAREXEL MyTrials™ platform, a fully-integrated eClinical solution that simplifies the clinical trial process. Developed by PAREXEL’s technology subsidiary Perceptive Informatics, PAREXEL MyTrials is an eClinical platform designed by clinical research experts to provide comprehensive support for the drug development process.

Please to read the entire article.